HIV News and Research RSS Feed - HIV News and Research

New approach could help tackle behavior change challenges across the globe

New approach could help tackle behavior change challenges across the globe

A new approach to behavior change which has been shown to successfully change hygiene, nutrition and exercise-related behaviors is described in a paper published in Health Psychology Review. [More]
Cold plasma therapy may help treat non-healing wounds

Cold plasma therapy may help treat non-healing wounds

Russian scientists at the Moscow Institute of Physics and Technology, the Joint Institute for High Temperatures of the Russian Academy of Sciences, and Gamaleya Research Centre of Epidemiology and Microbiology found that treating cells with cold plasma leads to their regeneration and rejuvenation. [More]
TSRI, IAVI scientists reveal new reductionist vaccine strategy to fight against HIV

TSRI, IAVI scientists reveal new reductionist vaccine strategy to fight against HIV

A series of new studies led by scientists at The Scripps Research Institute and the International AIDS Vaccine Initiative describe a potential vaccination strategy to jump-start the selection and evolution of broadly effective antibodies to prevent HIV infection. [More]
International researchers discover 44 novel gene sites linked to hypertension

International researchers discover 44 novel gene sites linked to hypertension

In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure. [More]
First accurate simulation reveals how virus shape changes when invading host cell

First accurate simulation reveals how virus shape changes when invading host cell

For the first time, scientists know what happens to a virus' shape when it invades a host cell, thanks to an experiment by researchers at Penn State College of Medicine and University of Pittsburgh School of Medicine. [More]
Virginia Mason offers totally laparoscopic advanced surgery for removing tumors from pancreas

Virginia Mason offers totally laparoscopic advanced surgery for removing tumors from pancreas

Virginia Mason now offers the totally laparoscopic Whipple procedure as an advanced surgical option for removing tumors from the head of the pancreas. [More]
Right dose of CAR T cells and lymphodepletion can achieve good response rates for NHL patients

Right dose of CAR T cells and lymphodepletion can achieve good response rates for NHL patients

In a paper published today in Science Translational Medicine, researchers from Fred Hutchinson Cancer Research Center shared data from an early-phase study of patients with advanced non-Hodgkin lymphoma (NHL) who received JCAR014, a Chimeric Antigen Receptor (CAR) T cell treatment, and chemotherapy. [More]
Study finds cord blood transplant recipients appear to have better outcomes against leukemia

Study finds cord blood transplant recipients appear to have better outcomes against leukemia

Umbilical cord blood transplants may have advantages beyond offering an alternative stem cell source for leukemia patients without a traditional donor match, according to a study published today in The New England Journal of Medicine. [More]
Registered nurse midwives could be useful untapped resource for infant circumcision in Africa

Registered nurse midwives could be useful untapped resource for infant circumcision in Africa

A new study indicates that early infant circumcision, which helps to prevent HIV transmission later in life, can be safely performed in rural Uganda. [More]
Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Global health experts are today are calling for the removal of restrictions preventing people who use drugs from accessing new hepatitis C cures. So long as these restrictions exist, the goal of disease elimination will remain out of reach, they say. [More]
Researchers discover second line of defense in macaques co-infected with Mtb and SIV

Researchers discover second line of defense in macaques co-infected with Mtb and SIV

Tulane University researchers found some monkeys whose immune systems are depleted by the simian strain of HIV have a second line of defense against tuberculosis. [More]
Gut bacteria may play role in immune recovery of HIV patients

Gut bacteria may play role in immune recovery of HIV patients

An international study coordinated by Spanish research institutes has found that gut bacteria also play their role in the immune recovery of HIV patients. [More]
New mathematical model could help predict potential outbreaks of Ebola and Lassa fever

New mathematical model could help predict potential outbreaks of Ebola and Lassa fever

Potential outbreaks of diseases such as Ebola and Lassa fever may be more accurately predicted thanks to a new mathematical model developed by researchers at the University of Cambridge. [More]
University of Nebraska-Lincoln wins $11.3 million NIH grant to establish CIBC

University of Nebraska-Lincoln wins $11.3 million NIH grant to establish CIBC

The University of Nebraska-Lincoln has earned an $11.3 million grant from the National Institutes of Health to establish a research center focused on investigating cellular level miscommunications that contribute to complex diseases such as cancer, diabetes and chronic liver disease. [More]
Researcher receives NIH grant to detect increasing Mtb activity in people with HIV

Researcher receives NIH grant to detect increasing Mtb activity in people with HIV

Tuberculosis (TB) is the leading cause of death worldwide among people infected with HIV. [More]
Specialty pharmaceuticals: an interview with David Moran, Clinigen SP

Specialty pharmaceuticals: an interview with David Moran, Clinigen SP

Specialty pharmaceuticals as a category has its origins in the 1970s with complex treatments being developed for disease areas such as cancer, HIV and haemophilia and what characterises a specialty pharmaceutical product is that it will be high touch, high complexity or high cost and is often associated with the treatment of rare or orphan conditions. These products require a considerable amount of expertise, innovation and technology and can be expensive as a result. [More]
Hitchhiking of drugs on incorrect targets can cause adverse side effects

Hitchhiking of drugs on incorrect targets can cause adverse side effects

It probably isn't surprising to read that pharmaceutical drugs don't always do what they're supposed to. Adverse side effects are a well-known phenomenon and something many of us will have experienced when taking medicines. [More]
Liver cancer time-bomb as up to 70% people with Hep C miss out on follow-up testing

Liver cancer time-bomb as up to 70% people with Hep C miss out on follow-up testing

Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say. [More]
Research supports potential role for cognitive activity in prevention of Alzheimer's disease

Research supports potential role for cognitive activity in prevention of Alzheimer's disease

Are there any ways of preventing or delaying the development of Alzheimer's disease or other forms of age-associated dementia? While several previously published studies have suggested a protective effect for cognitive activities such as reading, playing games or attending cultural events, questions have been raised about whether these studies reveal a real cause-and-effect relationship or if the associations could result from unmeasured factors. [More]
HIV-infected adults with MDD more likely to experience heart attack, study shows

HIV-infected adults with MDD more likely to experience heart attack, study shows

Among more than 26,000 human immunodeficiency virus (HIV)-infected adults, those with major depressive disorder (MDD) were more likely to experience a heart attack than those without MDD, according to a study published online by JAMA Cardiology. [More]
Advertisement